Enhanced expression and activity of DNA polymerase beta in chronic myelogenous leukemia

Anticancer Res. Jan-Feb 2006;26(1B):523-5.

Abstract

Background: Chronic myelogenous leukemia (CML) is characterized by an initial chronic phase that invariably evolves to the more aggressive phase of blast crisis. Although the determinants of this transition are still unknown, it has been shown that the blast crisis is accompanied by genetic instability.

Materials and methods: The expression and activity of the error-prone DNA polymerase beta (pol beta) were investigated in blood samples from CML patients, by Western blotting and by an in vitro replication assay, respectively.

Results: Pol beta expression and activity were significantly higher in CML samples compared to those of healthy donors.

Conclusion: Our results suggest that the excess of pol beta in CML could contribute to the genetic instability observed during the evolution of the disease from the chronic phase to blast crisis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blotting, Western
  • DNA Polymerase beta / biosynthesis
  • DNA Polymerase beta / blood*
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / blood
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / enzymology*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Neutrophils / enzymology

Substances

  • DNA Polymerase beta